Examining attorneys at the U.S. Patent and Trademark Office (USPTO) are citing a recent 2020 decision by the Trademark Trial and Appeal Board (TTAB) to support the position that trademarks for many products (particularly...more
3/26/2021
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
FDA Approval ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Intellectual Property Protection ,
Marijuana ,
Pharmaceutical Industry ,
Plant Based Products ,
Prescription Drugs ,
Trademark Application ,
Trademark Registration ,
Trademark Trial and Appeal Board ,
Trademarks ,
USPTO
While the country wrestles with the coronavirus pandemic, the federal government and many state governments recently made key determinations that could shape the future of the cannabis, hemp, and CBD industries for years to...more
4/11/2020
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
Controlled Substances Act ,
Coronavirus/COVID-19 ,
DEA ,
Decriminalization of Marijuana ,
Dispensaries ,
Marijuana ,
Marijuana Related Businesses ,
Operators of Essential Services ,
Patent Registration ,
Regulatory Agenda ,
Regulatory Oversight ,
Retail Market ,
USPTO
The United States Patent and Trademark Office (USPTO or Office) issued an examination guide on Friday, May 2, 2019, regarding the examination of trademarks for cannabis and cannabis-related goods and services after the...more